Publication:
Action Needed : Spiraling Drug Prices Empty Russian Pockets

Simple item page
dc.contributor.authorMarquez, Patricio
dc.contributor.authorBonch-Osmolovskiy, Mikhail
dc.date.accessioned2012-08-13T10:44:33Z
dc.date.available2012-08-13T10:44:33Z
dc.date.issued2010-02
dc.description.abstractIn large measure, this is due to the relatively low level of public health spending in the country (about 3.6 percent of gross domestic product (GDP) in 2008) that underlines the significant gap between the constitutional commitment to a range of medical care services and the actual funding to pay for them. While drugs are supposed to be provided to hospital patients free of charge, an estimated 80 percent of inpatients still have to pay part of the costs of their medicines and most outpatients must purchase them from pharmacies. The outpatient drug program under mandatory health insurance covers only around 16 million people (11 percent of the total population in the country), with more than half of them opting to receive cash rather than in-kind benefits under the 2005 'monetization' of prescription drug benefits. Those who continue with the in-kind benefits appear to be the ones greatest in need of drugs. The situation is further aggravated by the country's ineffective enforcement of controls on wholesale and retail mark-ups for medicines. Household expenditure on drugs accounted for about 30 percent of total health expenditure in Russia, as compared to 12 percent in Organization for Economic Co-operation and Development (OECD) countries in 2008.en
dc.identifierhttp://documents.worldbank.org/curated/en/2010/02/11900772/action-needed-spiraling-drug-prices-empty-russian-pockets
dc.identifier.doi10.1596/10211
dc.identifier.urihttps://hdl.handle.net/10986/10211
dc.languageEnglish
dc.publisherWorld Bank, Washington, DC
dc.relation.ispartofseriesEurope and Central Asia Knowledge Brief; Volume No. 19
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo/
dc.subjectASPIRIN
dc.subjectBRAND
dc.subjectBRAND NAME
dc.subjectBRAND NAME DRUGS
dc.subjectCARDIOVASCULAR DISEASES
dc.subjectCHRONIC DISEASE
dc.subjectCHRONIC DISEASES
dc.subjectCLINICAL GUIDELINES
dc.subjectCOMPETITIVENESS
dc.subjectCONSUMER PRICE
dc.subjectCONSUMER PRICE INDEX
dc.subjectDEMOGRAPHIC CHANGE
dc.subjectDEPRECIATION
dc.subjectDIABETES
dc.subjectDRUG LIST
dc.subjectDRUG POLICIES
dc.subjectDRUG PRICES
dc.subjectDRUG RESISTANCE
dc.subjectDRUGS
dc.subjectESSENTIAL DRUGS
dc.subjectESSENTIAL MEDICINES
dc.subjectEXPENDITURE
dc.subjectEXPENDITURES
dc.subjectFAMILIES
dc.subjectGENERIC DRUGS
dc.subjectGENERIC EQUIVALENTS
dc.subjectHEALTH CARE
dc.subjectHEALTH ECONOMICS
dc.subjectHEALTH INFORMATION SYSTEMS
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH OUTCOMES
dc.subjectHEALTH PROBLEMS
dc.subjectHEALTH REFORM
dc.subjectHEALTH RESEARCH
dc.subjectHEALTH SERVICES
dc.subjectHEALTH SYSTEM
dc.subjectHOSPITAL
dc.subjectHOSPITAL CARE
dc.subjectHOSPITAL PATIENTS
dc.subjectHOSPITALIZATION
dc.subjectHUMAN DEVELOPMENT
dc.subjectHYPERTENSION
dc.subjectILL HEALTH
dc.subjectILLNESSES
dc.subjectINFORMED DECISIONS
dc.subjectINJURIES
dc.subjectINSULIN
dc.subjectINTERNATIONAL MARKET
dc.subjectMARKETING
dc.subjectMEDICAL CARE
dc.subjectMEDICAL EDUCATION
dc.subjectMEDICINES
dc.subjectMENTAL DISORDERS
dc.subjectMORTALITY
dc.subjectPATIENT
dc.subjectPATIENTS
dc.subjectPHARMACEUTICAL
dc.subjectPHARMACEUTICAL INDUSTRY
dc.subjectPHARMACEUTICALS
dc.subjectPHARMACIES
dc.subjectPHYSICIANS
dc.subjectPOLICY MAKERS
dc.subjectPOPULATION GROUPS
dc.subjectPRICE CONTROLS
dc.subjectPRICE INCREASE
dc.subjectPRICE INCREASES
dc.subjectPRICE INFLATION
dc.subjectPROCUREMENT
dc.subjectPUBLIC HEALTH
dc.subjectRATIONAL DRUG USE
dc.subjectRETAIL
dc.subjectRETAIL PRICE
dc.subjectRETAIL PRICES
dc.subjectSALES
dc.subjectSOCIAL SECTORS
dc.subjectSOCIAL WELFARE
dc.subjectSUPPLIERS
dc.subjectTENDERING
dc.subjectTHERAPIES
dc.subjectTUBERCULOSIS
dc.subjectUNEMPLOYMENT
dc.subjectWHOLESALE PRICES
dc.titleAction Needed : Spiraling Drug Prices Empty Russian Pocketsen
dspace.entity.typePublication
okr.date.doiregistration2025-04-29T09:21:51.192662Z
okr.doctypePublications & Research::Brief
okr.doctypePublications & Research
okr.docurlhttp://documents.worldbank.org/curated/en/2010/02/11900772/action-needed-spiraling-drug-prices-empty-russian-pockets
okr.globalpracticeMacroeconomics and Fiscal Management
okr.globalpracticeHealth, Nutrition, and Population
okr.globalpracticeGovernance
okr.globalpracticeFinance and Markets
okr.globalpracticeHealth, Nutrition, and Population
okr.guid918871468107679209
okr.guid218021468107678906
okr.identifier.externaldocumentum000333038_20100305041450
okr.identifier.internaldocumentum11900772
okr.identifier.report53325
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2010/03/05/000333038_20100305041450/Rendered/PDF/533250BRI0ECA01Box345607B001PUBLIC1.pdfen
okr.region.administrativeEurope and Central Asia
okr.region.countryRussian Federation
okr.topicLaw and Development::Health Law
okr.topicHealth, Nutrition and Population::Population Policies
okr.topicHealth Monitoring and Evaluation
okr.topicMacroeconomics and Economic Growth::Markets and Market Access
okr.topicPharmaceuticals and Pharmacoeconomics
okr.unitHealth and Nutrition (ECSH1)
okr.unitOffice of the Regional Vice Pres (ECAVP)
okr.volume1 of 1
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
533250BRI0ECA01Box345607B001PUBLIC1.pdf
Size:
779.38 KB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
533250BRI0ECA01Box345607B001PUBLIC1.txt
Size:
30.4 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Europe and Central Asia Knowledge Brief